BlackRock Fund Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $70.8M | Buy |
2,221,302
+388,206
| +21% | +$12.4M | 0.01% | 1447 |
|
|
2016
Q3 | $66.4M | Buy |
1,833,096
+47,389
| +3% | +$1.72M | 0.01% | 1373 |
|
|
2016
Q2 | $40.5M | Buy |
1,785,707
+218,112
| +14% | +$4.95M | 0.01% | 1630 |
|
|
2016
Q1 | $29.5M | Sell |
1,567,595
-16,307
| -1% | -$307K | 0.01% | 1762 |
|
|
2015
Q4 | $26M | Sell |
1,583,902
-17,538
| -1% | -$287K | 0.01% | 1882 |
|
|
2015
Q3 | $17.6M | Sell |
1,601,440
-108,249
| -6% | -$1.19M | ﹤0.01% | 2066 |
|
|
2015
Q2 | $22.3M | Buy |
1,709,689
+209,612
| +14% | +$2.73M | 0.01% | 2046 |
|
|
2015
Q1 | $26M | Buy |
1,500,077
+299,928
| +25% | +$5.2M | 0.01% | 1932 |
|
|
2014
Q4 | $17.9M | Buy |
1,200,149
+432,587
| +56% | +$6.45M | ﹤0.01% | 2129 |
|
|
2014
Q3 | $17.7M | Sell |
767,562
-50,620
| -6% | -$1.17M | 0.01% | 2034 |
|
|
2014
Q2 | $26.1M | Buy |
+818,182
| New | +$26.1M | 0.01% | 1851 |
|